Cargando…
Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645288/ http://dx.doi.org/10.1186/2051-1426-3-S2-O2 |
_version_ | 1782400799991660544 |
---|---|
author | Gros, Alena Tran, Eric Parkhurst, Maria R Anna, Pasetto Ilyas, Sadia Prickett, Todd D Gartner, Jared J Robbins, Paul F Crystal, Jessica S Trebska-Mcgowan, Kasia Wudnerlich, John R Yang, James C Rosenberg, Steven A |
author_facet | Gros, Alena Tran, Eric Parkhurst, Maria R Anna, Pasetto Ilyas, Sadia Prickett, Todd D Gartner, Jared J Robbins, Paul F Crystal, Jessica S Trebska-Mcgowan, Kasia Wudnerlich, John R Yang, James C Rosenberg, Steven A |
author_sort | Gros, Alena |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4645288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46452882015-11-20 Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes Gros, Alena Tran, Eric Parkhurst, Maria R Anna, Pasetto Ilyas, Sadia Prickett, Todd D Gartner, Jared J Robbins, Paul F Crystal, Jessica S Trebska-Mcgowan, Kasia Wudnerlich, John R Yang, James C Rosenberg, Steven A J Immunother Cancer Oral Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645288/ http://dx.doi.org/10.1186/2051-1426-3-S2-O2 Text en Copyright © 2015 Gros et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Gros, Alena Tran, Eric Parkhurst, Maria R Anna, Pasetto Ilyas, Sadia Prickett, Todd D Gartner, Jared J Robbins, Paul F Crystal, Jessica S Trebska-Mcgowan, Kasia Wudnerlich, John R Yang, James C Rosenberg, Steven A Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title | Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title_full | Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title_fullStr | Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title_full_unstemmed | Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title_short | Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
title_sort | selection of circulating pd-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645288/ http://dx.doi.org/10.1186/2051-1426-3-S2-O2 |
work_keys_str_mv | AT grosalena selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT traneric selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT parkhurstmariar selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT annapasetto selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT ilyassadia selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT pricketttoddd selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT gartnerjaredj selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT robbinspaulf selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT crystaljessicas selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT trebskamcgowankasia selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT wudnerlichjohnr selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT yangjamesc selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes AT rosenbergstevena selectionofcirculatingpd1lymphocytesfromcancerpatientsenrichesfortumorreactiveandmutationspecificlymphocytes |